Literature DB >> 20394539

Nanomicellar formulations for sustained drug delivery: strategies and underlying principles.

Ruchit Trivedi1, Uday B Kompella.   

Abstract

Micellar delivery systems smaller than 100 nm can be readily prepared. While micelles allow a great depth of tissue penetration for targeted drug delivery, they usually disintegrate rapidly in the body. Thus, sustained drug delivery from micellar nanocarriers is a challenge. This article summarizes various key strategies and underlying principles for sustained drug delivery using micellar nanocarriers. Comparisons are made with other competing delivery systems such as polymeric microparticles and nanoparticles. Amphiphilic molecules self-assemble in appropriate liquid media to form nanoscale micelles. Strategies for sustained release nanomicellar carriers include use of prodrugs, drug polymer conjugates, novel polymers with low critical micellar concentration or of a reverse thermoresponsive nature, reverse micelles, multi-layer micelles with layer by layer assembly, polymeric films capable of forming micelles in vivo and micelle coats on a solid support. These new micellar systems are promising for sustained drug delivery.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20394539      PMCID: PMC2902878          DOI: 10.2217/nnm.10.10

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  50 in total

1.  Poly(lactide)-poly(ethylene glycol) micelles as a carrier for griseofulvin.

Authors:  E Pierri; K Avgoustakis
Journal:  J Biomed Mater Res A       Date:  2005-12-01       Impact factor: 4.396

2.  Eligard: leuprolide acetate in a novel sustained-release delivery system.

Authors:  Oliver Sartor
Journal:  Urology       Date:  2003-02       Impact factor: 2.649

3.  Potent antitumor effect of SN-38-incorporating polymeric micelle, NK012, against malignant glioma.

Authors:  Jun-ichiro Kuroda; Jun-ichi Kuratsu; Masahiro Yasunaga; Yoshikatsu Koga; Yohei Saito; Yasuhiro Matsumura
Journal:  Int J Cancer       Date:  2009-06-01       Impact factor: 7.396

4.  Encapsulation of the synthetic retinoids Am80 and LE540 into polymeric micelles and the retinoids' release control.

Authors:  Taku Satoh; Yuriko Higuchi; Shigeru Kawakami; Mitsuru Hashida; Hiroyuki Kagechika; Koichi Shudo; Masayuki Yokoyama
Journal:  J Control Release       Date:  2009-03-14       Impact factor: 9.776

5.  Biodegradable polymeric micelles composed of doxorubicin conjugated PLGA-PEG block copolymer.

Authors:  H S Yoo; T G Park
Journal:  J Control Release       Date:  2001-01-29       Impact factor: 9.776

6.  Core crosslinking of biodegradable block copolymer micelles based on poly(ester carbonate).

Authors:  Xiuli Hu; Xuesi Chen; Jizheng Wei; Shi Liu; Xiabin Jing
Journal:  Macromol Biosci       Date:  2009-05-13       Impact factor: 4.979

7.  Enhanced in vivo antitumor efficacy of fenretinide encapsulated in polymeric micelles.

Authors:  Tomoyuki Okuda; Shigeru Kawakami; Yuriko Higuchi; Taku Satoh; Yoshimi Oka; Masayuki Yokoyama; Fumiyoshi Yamashita; Mitsuru Hashida
Journal:  Int J Pharm       Date:  2009-01-31       Impact factor: 5.875

8.  Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelle nanocarriers: pharmacokinetic disposition, tolerability, and cytotoxicity.

Authors:  M Laird Forrest; Jaime A Yáñez; Connie M Remsberg; Yusuke Ohgami; Glen S Kwon; Neal M Davies
Journal:  Pharm Res       Date:  2007-10-03       Impact factor: 4.200

9.  Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with pluronic P105/poly(caprolactone) copolymers.

Authors:  Yongzhong Wang; Yajuan Li; Qisong Wang; Xiaoling Fang
Journal:  Pharmazie       Date:  2008-06       Impact factor: 1.267

10.  Preparation, pharmacokinetics and tissue distribution of micelles made of reverse thermo-responsive polymers.

Authors:  Xingguo Yang; Lingbing Li; Yuexia Wang; Yebang Tan
Journal:  Int J Pharm       Date:  2008-12-07       Impact factor: 5.875

View more
  56 in total

Review 1.  Imaging and drug delivery using theranostic nanoparticles.

Authors:  Siti M Janib; Ara S Moses; J Andrew MacKay
Journal:  Adv Drug Deliv Rev       Date:  2010-08-13       Impact factor: 15.470

Review 2.  Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies.

Authors:  Abhirup Mandal; Rohit Bisht; Ilva D Rupenthal; Ashim K Mitra
Journal:  J Control Release       Date:  2017-01-11       Impact factor: 9.776

Review 3.  Towards nanomedicines for neuroAIDS.

Authors:  Vidya Sagar; Sudheesh Pilakka-Kanthikeel; Ravi Pottathil; Shailendra K Saxena; Madhavan Nair
Journal:  Rev Med Virol       Date:  2014-01-07       Impact factor: 6.989

Review 4.  Polymeric materials for theranostic applications.

Authors:  Zhe Wang; Gang Niu; Xiaoyuan Chen
Journal:  Pharm Res       Date:  2013-06-14       Impact factor: 4.200

Review 5.  Stimuli-responsive liposomes for drug delivery.

Authors:  Y Lee; D H Thompson
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-02-15

6.  Peptide-micelle hybrids containing fasudil for targeted delivery to the pulmonary arteries and arterioles to treat pulmonary arterial hypertension.

Authors:  Nilesh Gupta; Hany M Ibrahim; Fakhrul Ahsan
Journal:  J Pharm Sci       Date:  2014-09-29       Impact factor: 3.534

7.  Investigation on the Linear and Nonlinear Properties of Morin in Presence of Reverse Micelle and Different Oil Content in Reverse Micelle.

Authors:  Abbas Rahdar; Esmael Sanchooli; R Karimzadeh; Dibakar Sahoo
Journal:  J Fluoresc       Date:  2021-01-04       Impact factor: 2.217

8.  Nanomicelles: an emerging platform for drug delivery to the eye.

Authors:  Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Ther Deliv       Date:  2013-01

Review 9.  Nano-ART and NeuroAIDS.

Authors:  Malay K Das; Anupam Sarma; Tapash Chakraborty
Journal:  Drug Deliv Transl Res       Date:  2016-10       Impact factor: 4.617

10.  Aqueous nanomicellar formulation for topical delivery of biotinylated lipid prodrug of acyclovir: formulation development and ocular biocompatibility.

Authors:  Aswani Dutt Vadlapudi; Kishore Cholkar; Ramya Krishna Vadlapatla; Ashim K Mitra
Journal:  J Ocul Pharmacol Ther       Date:  2013-11-05       Impact factor: 2.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.